Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Research article · 2012 Article · 20 Aug 2026 Systematic review of mitochondrial genome alterations in cancer patients: Insights from mtDNA mutations and their implications for disease progression and therapeutics
Mitochondrial DNA (mtDNA) mutations have been shown in the past few years to be important in the study of many cancers. However, while those mutations led to mitochondrial dysfunction
Article · 26 Feb 2026 Evolution and Production of a Clinical-Grade Adenovirus Expressing the Transgene Tissue Inhibitor of Metalloproteinase-3 (TIMP-3) Through Genome Engineering
HAdV5 variants with different transgene configurations, including reversion of E1 DNA sequence. Loss of TIMP-3 expression, vector mutations and sequence rearrangements were observed in multiple clones from each…
Article · 19 Feb 2026 Recent Trends in Gene Editing Technology CRISPR Cas9
bacterial immune system repurposed for precise genectic modification, allows for targeted alterations in the DNA of various organisms with unprecedented accuracy and efficiency. This technology has rapidly become a…
Perspective · 1 Dec 2025 Chromatin Remodeling: Orchestrating Gene Expression and Disease
dynamics, histone variants, and chromatin’s role in DNA damage response and nuclear organization all contribute to this complex regulatory network. Mutations in chromatin remodeling genes are hallmarks of many
Perspective · 26 Nov 2025 Cancer: Multifaceted Mechanisms and Therapeutic Targets
Carcinogenesis is a complex process driven by genetic and epigenetic alterations, the
Commentary · 26 Nov 2025 Oncology’s Future: Diverse, Personalized, Advanced Strategies
Modern oncology is marked by rapid advancements in personalized treatment and diagnostic
Short communication · 29 Oct 2025 Tumor Suppressor Genes: Cancer Prevention and Therapeutic Targets
mutation or epigenetic silencing is common in cancer. This review discusses the roles of key tumor suppressors like RB, TP53, BRCA1/2, PTEN, and APC in cell cycle regulation, DNA
Editorial · 29 Oct 2025 Biomarker Discovery and AI for Precision Oncology
techniques, including circulating tumor DNA and extracellular vesicles, are pivotal. Artificial intelligence integrates multi-omics data for biomarker discovery. Proteomics, epigenetics, metabolomics, and somatic…
Case report · 29 Aug 2025 Ovarian Cancer Prognosis: Biomarkers for Prediction and Guidance
Prognostic biomarkers are essential for optimizing ovarian cancer treatment and improving patient
Research article · 29 Aug 2025 Ovarian Cancer: Tumor Suppressor Genes, Mutations, and Therapies
suppressor genes are critical in preventing ovarian cancer by regulating cell growth, DNA repair, and apoptosis. Mutations in key genes like TP53, BRCA1, and BRCA2 disrupt these processes, leading
Editorial · 29 Jul 2025 Immune Checkpoint Blockade: Evolving Biomarker Landscape
immune checkpoint blockade in solid tumors. Established markers include PD-L1 expression, \textit{Tumor Mutational Burden} (TMB), and Microsatellite Instability (MSI), guiding personalized treatment. Understanding…
Editorial · 29 Jul 2025 Precision Oncology: Biomarkers, Multi-Omics, AI
DNA and liquid biopsies offer non-invasive detection and monitoring. Advanced sequencing, spatial multi-omics, and single-cell analysis provide deep insights into tumor biology. Key biomarkers like Tumor Mutational
Editorial · 29 Jul 2025 ctDNA: Transforming Precision Oncology, Non-invasively
Circulating tumor \textit{DNA} (ctDNA) represents a significant advancement in precision oncology, offering a non-invasive method for comprehensive tumor characterization. Its utility spans genetic profiling, real-time…
Short communication · 30 Jun 2025 Chemoresistance in Cancer: Mechanisms, Molecular Drivers, and Emerging Therapeutic Strategies
chemoresistance are multifactorial and involve genetic mutations, epigenetic alterations, drug efflux pump overexpression, tumor microenvironment interactions, cancer stem cell persistence, and enhanced DNA repair…
Article · 27 May 2025 Olaparib efficacy in malignancies not typically associated with homologous repair deficiency
targeting poly(ADPribose) polymerase (PARP), which is responsible for repairing single-stranded deoxyribonucleic acid (DNA) breaks, in tumors with HRD including deficiencies in BRCA1/2 and associated proteins. PARP…
Research article · 23 May 2025 Identification of Haplogroups and Molecular Markers in Skeletal Samples Excavated from the Ancient City of Resuloğlu (Uğurludağ, Çorum)
Mitochondrial DNA analyses were carried out in order to determine the haplogroups of 6 individuals obtained from the cemetery of Resuloğlu and dated to the Early Bronze ... Neolithic period. Furthermore, a detailed…
Research article · 9 Apr 2025 ?MYB-Related Protein P-Like? is the Candidate Gene Homologus to ZmMYBIF35 R2R3-Transcription Factor in Wheat (Triticum aestivum L.) for Anythocyanin Pathway Modifications
regulation of RNA biosynthesis process majorly and it binds to the nucleic acids/DNA. No phosphorylation was shown as post translational modification apart from glycosylation between 150-200 amino acid residues ... were…
Commentary · 31 Mar 2025 Personalizing Osteosarcoma Therapy: The Role of Immune Checkpoints and Biomarkers
CTLA-4 in osteosarcoma, and how emerging biomarkers including tumor mutational burden, immune cell infiltration profiles, and circulating tumor DNA may enable more tailored and effective therapies. We discuss current
Editorial · 31 Mar 2025 Epigenomics: Unlocking the Regulatory Layer of the Genome
modifications, including DNA methylation, histone modifications, and chromatin remodeling, play a crucial role in regulating cellular processes such as development, differentiation, and disease progression. Unlike…
Perspective · 29 Mar 2025 CRISPR/Cas9 Nanodelivery: Advancing Precision Genome
revolutionary genome editing tool, allowing precise, efficient, and cost-effective modifications in DNA sequences. Its applications span medicine, agriculture, and biotechnology, including disease therapy, crop…
Conference abstract · 17 Mar 2025 Neurogenetics of Costello syndrome
achieved through disruption of gain-of-function pathogenic mutation, restoration of loss-of-function mutation, addition of a transgene essential for cell function and single nucleotide changes. Development of genome…
Research article · 1 Mar 2025 Experimental Multidrug Treatment of Chagas Disease
protist Trypanosoma cruzi inserts kinetoplast DNA (kDNA) minicircle sequences into the host genome and the mutations generate genetically driven Chagas disease in chicken’s refractory to the parasite infection. Chicks…
Perspective · 28 Feb 2025 Role of PARP Inhibitors in Ovarian Cancer
cause of gynecologic cancer mortality, is characterized by DNA repair deficiencies in up to 50% of cases, particularly in BRCA-mutated and homologous recombination-deficient (HRD) tumors. Poly (ADPribose) polymerase
Commentary · 27 Feb 2025 The Impact of Genomic Instability on Cervical Cancer Progression
plays a crucial role in cervical cancer development. The accumulation of genetic mutations, chromosomal aberrations, and DNA repair deficiencies contribute to tumor initiation, progression, and resistance to therapy…

